Immuno-Oncology: From Science Fiction to the Mainstream
In just a couple of decades, immuno-oncology has taken center stage in the biotechnology industry.…
May 26, 2021 - 7 minutes
Immatics
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
December 28, 2020 - 12 minutes
Why are Some European Biotechs Going Public Without an IPO?
European biotech companies are flocking to the Nasdaq Stock Market in 2020, but not all…
August 13, 2020 - 7 minutes
Immatics Partners GSK in Deal Worth €1B to Develop Cancer Therapies
The German biotech Immatics will partner with GSK and could receive more than €1B from…
February 20, 2020 - 3 minutes
Why Being in a New Field From the Start Can Pay Off in the Long Run
The field of immuno-oncology has expanded out of all recognition over the last few years.…
September 7, 2019 - 12 minutes
Celgene and Immatics Sign Deal Worth Over €1.35B to Develop Cancer Immunotherapies
The US company Celgene has obtained options to three cancer immunotherapy programs from the German…
August 28, 2019 - 3 minutes
Personalized Immunotherapy for Brain Cancer Succeeds in Clinical Trials
A European trial has proved the feasibility and efficacy of treating cancer with a personalized…
December 20, 2018 - 3 minutes
Money, Money, Money! Europe’s Best-Funded Biotechs in 2018
Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where…
February 20, 2018 - 11 minutes
Amgen Joins €50M German Fundraising for T-Cell Receptor Cancer Immunotherapy
Immatics has completed a $58M (€50M) round with the participation of Amgen, not long after both…
October 4, 2017 - 2 minutes
German Pharma Enters the Clinic with Solid Tumor Treatment
A Phase I study will investigate the safety and tolerability of Immatics approach to treating…
September 28, 2017 - 2 minutes
German Biotech Starts Trials with a Personalized Cell Therapy for Multiple Cancers
Immatics will start a first clinical trial to test IMA101, a personalized cell therapy with…
August 21, 2017 - 3 minutes
Infographic: What’s in Europe’s Immuno-oncology Pipeline?
While some might accuse the field of being over-hyped, immuno-oncology continues to attract attention and investment for…
February 13, 2017 - 2 minutes
